MC
TMO icon

Miles Capital’s Thermo Fisher Scientific TMO Stock Holding History

Miles Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$1.05M Buy
3,701
+250
+7% +$78.8K 1.13% 19
2019
Q4 		$1.12M Buy
3,451
+275
+9% +$83.4K 0.9% 22
2019
Q3 		$925K Sell
3,176
-102
-3% -$29.2K 0.76% 33
2019
Q2 		$963K Buy
3,278
+1,686
+106% +$464K 0.79% 31
2019
Q1 		$436K Sell
1,592
-98
-6% -$24.4K 0.38% 72
2018
Q4 		$378K Sell
1,690
-19
-1% -$4.46K 0.37% 74
2018
Q3 		$417K Buy
1,709
+512
+43% +$118K 0.34% 75
2018
Q2 		$248K Sell
1,197
-11
-0.9% -$2.33K 0.15% 143
2018
Q1 		$249K Buy
+1,208
New +$254K 0.14% 163
2016
Q3 		– Sell
-2,195
Closed -$324K – 204
2016
Q2 		$324K Sell
2,195
-1,629
-43% -$240K 0.22% 102
2016
Q1 		$541K Sell
3,824
-47
-1% -$6.3K 0.36% 66
2015
Q4 		$549K Sell
3,871
-175
-4% -$23.3K 0.37% 73
2015
Q3 		$495K Sell
4,046
-94
-2% -$12.2K 0.36% 74
2015
Q2 		$537K Buy
+4,140
New +$540K 0.35% 78

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Miles Capital's TMO Position: Q1 2020 in Review

Miles Capital increased its Thermo Fisher Scientific (TMO) stake by 7.2% in Q1 2020, buying an estimated $78.8K and bringing the position to 3,701 shares worth $1.05M. The position accounts for 1.13% of the portfolio, ranked #19.

Miles Capital first reported a position in TMO in Q2 2015 and has held it in 14 quarters since. The position peaked at $1.12M in Q4 2019. 1,674 funds tracked by Wall St. Rank hold TMO as of Q1 2020.

  • Miles Capital held 3,701 shares of Thermo Fisher Scientific worth $1.05M as of Q1 2020.
  • Miles Capital bought 250 Thermo Fisher Scientific shares in Q1 2020, an estimated $78.8K.
  • Thermo Fisher Scientific made up 1.13% of Miles Capital's portfolio in Q1 2020, its #19 holding.
  • Miles Capital first reported a position in Thermo Fisher Scientific in Q2 2015 and has held it in 14 quarters since.
  • Miles Capital's Thermo Fisher Scientific position peaked at $1.12M in Q4 2019.
  • 1,674 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2020.

Based on Miles Capital's 13F filing for Q1 2020, filed 13 May 2020.